Multiply Labs develops robotic systems that manufacture individualized drugs at industrial scale.

Multiply Labs’ robotic systems leverage the latest advancements in autonomous technology – from collaborative robots to cloud-controlled fleets – to enable the production of individualized drugs at industrial scale.

• Industry

  • Advanced Manufacturing
  • Health + Tech
  • Robotics

• Milestones

  • Lux investment: 2021

• Founders

  • Fred Parietti, PhD
  • Alice Melocchi, PhD

  LUX Partners

  • Brandon Reeves

• Latest Tweets

  • We are happy to be featured with our partner @Cytiva in a comprehensive @FiercePharma review of the pioneering robo… https://t.co/20jTnkWYmV@multiplylabs - 11:08 PM Jul 26th
  • We are excited to announce the Consortium for robotic cell therapy manufacturing! We are partnering with global lea… https://t.co/1hNALNyyY6@multiplylabs - 02:59 PM May 13th
  • We are very happy to announce our Series A, led by @cascapital with the participation from @Lux_Capital and Pathfi… https://t.co/chfAYH7PEm@multiplylabs - 03:32 PM Apr 14th